#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Tuberous sclerosis complex Glycogen storage disease type II Von Willebrand's disease Skin angiosarcoma Deafness neurosensory Liposarcoma metastatic Small cell lung cancer recurrent Osteosarcoma metastatic Pseudomyxoma peritonei Cardiac sarcoidosis Peripheral primitive neuroectodermal tumour of soft tissue Spinal cord injury cervical Hepatitis D B-cell lymphoma recurrent Small intestine neuroendocrine tumour More trials…

    Learn about Rare Diseases

    Sarcoma – Trials in Disease Marginal zone lymphoma – Basic Information Synovial sarcoma metastatic – Trials in Disease Prolymphocytic leukaemia – Trials in Disease CADASIL – Life with Disease Adrenogenital syndrome – Basic Information Phenylketonuria Alexander disease Alveolar rhabdomyosarcoma – Basic Information Encephalitis autoimmune – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cabotegravir Sodium Bi 1291583 Vanzacaftor Elamipretide Trihydrochloride Amisulpride Ivermectin Osteodex Upacicalcet Sodium Hydrate Mexiletine Hydrochloride Ziftomenib Specific Nucleic Acid Sna-Papi F770/05 Isotretinoin Docetaxel Murcidencel Dorocubicel Carfilzomib Proguanil Hydrochloride Teprenone Sodium Lactate Solution More therapies…

    Learn about Your Condition

    Neuromuscular scoliosis Ocular melanoma Hepatic cancer Psychotic behaviour Adenocarcinoma gastric Vulvar dysplasia Hypertriglyceridaemia Infection Morning sickness Strongyloidiasis Overweight Actinic cheilitis Type V hyperlipidaemia Measles Marginal zone lymphoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Depression

  • Safety and dose‑finding study of trazodone hydrochloride and psilocybin in patients with treatment‑resistant depression

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • TRAZODONE HYDROCHLORIDE
    • Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
    Italy

  • Efficacy of high- and low-dose psilocybin in preventing relapse in adults with severe alcohol use disorder and depressive symptoms after detoxification

    Recruiting

    3 1 1
    Investigated Diseases:
    • Depression
    Investigated Drugs:
    • Psilocybine
    France

  • Testing a Pharmacogenetic-Guided Treatment Selection Strategy with Antidepressant Drug Combination for Patients with Depressive Disorder

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Depression
    Investigated Drugs:
    • TRIMIPRAMINE MALEATE
    • Agomelatine
    • Bupropion Hydrochloride
    Spain

  • Testing dehydroepiandrosterone combined with standard antidepressants for patients with treatment-resistant depression

    Recruiting

    3 1 1
    Investigated Diseases:
    • Depression
    Investigated Drugs:
    • Prasterone
    • Lactose Monohydrate
    Germany

  • Study of psilocybin compared to personalized rTMS treatment in adults with treatment-resistant depression

    Recruiting

    2 1
    Investigated Diseases:
    • Depression
    Investigated Drugs:
    • Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
    Italy

  • Study of Flumazenil to Reduce Side Effects of Electroconvulsive Therapy in Patients with Depression

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Depression
    Denmark
1 2 3 … 6
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!